SMMT Summit Therapeutics PLC ADRs

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.

$1.20  +0.01 (0.84%)
As of 10/03/2022 15:59:45 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  03/04/2015
Outstanding shares:  98,122,356
Average volume:  669,565
Market cap:   $112,840,709
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMTVQS7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.81
PS ratio:   0.00
Return on equity:   -143.64%
Net income %:   -4,955.06%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy